Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX – Get Rating) Director David B. Stevens sold 43,134 shares of the firm’s stock in a transaction dated Tuesday, December 6th. The stock was sold at an average price of $18.47, for a total value of $796,684.98. Following the completion of the transaction, the director now owns 32,384 shares of the company’s stock, valued at approximately $598,132.48. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Allscripts Healthcare Solutions Price Performance
Shares of MDRX traded down $0.17 during trading hours on Wednesday, reaching $18.33. 2,014,794 shares of the company’s stock traded hands, compared to its average volume of 1,575,549. The stock has a market cap of $2.00 billion, a PE ratio of 43.02, a price-to-earnings-growth ratio of 1.76 and a beta of 1.01. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.17. The firm’s 50 day simple moving average is $16.26 and its 200-day simple moving average is $16.22. Allscripts Healthcare Solutions, Inc. has a 12 month low of $13.59 and a 12 month high of $23.25.
Allscripts Healthcare Solutions (NASDAQ:MDRX – Get Rating) last announced its quarterly earnings data on Thursday, November 3rd. The software maker reported $0.23 earnings per share for the quarter, beating analysts’ consensus estimates of $0.19 by $0.04. The company had revenue of $151.90 million for the quarter, compared to analysts’ expectations of $152.79 million. Allscripts Healthcare Solutions had a return on equity of 10.74% and a net margin of 7.25%. Allscripts Healthcare Solutions’s revenue for the quarter was up 5.0% compared to the same quarter last year. During the same period last year, the firm posted $0.21 EPS. Equities analysts expect that Allscripts Healthcare Solutions, Inc. will post 0.65 EPS for the current year.
Analyst Ratings Changes
Several research analysts have commented on the company. Piper Sandler restated an “overweight” rating and issued a $17.00 target price on shares of Allscripts Healthcare Solutions in a research note on Friday, November 4th. JPMorgan Chase & Co. raised their target price on Allscripts Healthcare Solutions from $19.00 to $20.00 and gave the stock an “underweight” rating in a research note on Friday, November 18th. StockNews.com began coverage on Allscripts Healthcare Solutions in a research report on Wednesday, October 12th. They set a “hold” rating for the company. TheStreet upgraded Allscripts Healthcare Solutions from a “c+” rating to a “b-” rating in a research report on Wednesday, November 30th. Finally, The Goldman Sachs Group upgraded Allscripts Healthcare Solutions from a “neutral” rating to a “buy” rating and lifted their price target for the company from $22.00 to $23.00 in a research report on Tuesday, November 8th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, Allscripts Healthcare Solutions currently has a consensus rating of “Moderate Buy” and an average target price of $22.67.
Hedge Funds Weigh In On Allscripts Healthcare Solutions
Large investors have recently modified their holdings of the company. CWM LLC raised its holdings in shares of Allscripts Healthcare Solutions by 578.4% during the 3rd quarter. CWM LLC now owns 2,103 shares of the software maker’s stock valued at $32,000 after buying an additional 1,793 shares in the last quarter. C M Bidwell & Associates Ltd. purchased a new position in shares of Allscripts Healthcare Solutions during the 3rd quarter valued at about $33,000. Robeco Institutional Asset Management B.V. purchased a new position in shares of Allscripts Healthcare Solutions during the 3rd quarter valued at about $93,000. Hightower 6M Holding LLC purchased a new position in shares of Allscripts Healthcare Solutions during the 1st quarter valued at about $225,000. Finally, Ritholtz Wealth Management purchased a new position in shares of Allscripts Healthcare Solutions during the 3rd quarter valued at about $158,000. 99.76% of the stock is owned by hedge funds and other institutional investors.
Allscripts Healthcare Solutions Company Profile
Allscripts Healthcare Solutions, Inc, together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Allscripts Healthcare Solutions, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Allscripts Healthcare Solutions wasn’t on the list.
While Allscripts Healthcare Solutions currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here